Italy
· Delayed Price · Currency is EUR Banca Mediolanum Statistics
Total Valuation
BIT:BMED has a market cap or net worth of EUR 10.97 billion.
| Market Cap | 10.97B |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | Nov 18, 2024 |
Share Statistics
BIT:BMED has 737.48 million shares outstanding. The number of shares has increased by 0.49% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 737.48M |
| Shares Change (YoY) | +0.49% |
| Shares Change (QoQ) | -0.53% |
| Owned by Insiders (%) | 6.92% |
| Owned by Institutions (%) | 8.51% |
| Float | 243.05M |
Valuation Ratios
The trailing PE ratio is 9.93 and the forward PE ratio is 12.07.
| PE Ratio | 9.93 |
| Forward PE | 12.07 |
| PS Ratio | 4.66 |
| PB Ratio | 2.72 |
| P/TBV Ratio | 2.88 |
| P/FCF Ratio | 9.65 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.10 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 29.93%.
| Return on Equity (ROE) | 29.93% |
| Return on Assets (ROA) | 1.37% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 616,316 |
| Profits Per Employee | 292,713 |
| Employee Count | 3,825 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.76% in the last 52 weeks. The beta is 1.29, so BIT:BMED's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | +46.76% |
| 50-Day Moving Average | 13.78 |
| 200-Day Moving Average | 11.78 |
| Relative Strength Index (RSI) | 64.66 |
| Average Volume (20 Days) | 1,771,436 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIT:BMED had revenue of EUR 2.36 billion and earned 1.12 billion in profits. Earnings per share was 1.50.
| Revenue | 2.36B |
| Gross Profit | 2.35B |
| Operating Income | 1.51B |
| Pretax Income | 1.45B |
| Net Income | 1.12B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 1.50 |
Balance Sheet
The company has 42.71 billion in cash and 6.94 billion in debt, giving a net cash position of 35.77 billion or 48.51 per share.
| Cash & Cash Equivalents | 42.71B |
| Total Debt | 6.94B |
| Net Cash | 35.77B |
| Net Cash Per Share | 48.51 |
| Equity (Book Value) | 4.03B |
| Book Value Per Share | 5.46 |
| Working Capital | -10.02B |
Cash Flow
In the last 12 months, operating cash flow was 1.15 billion and capital expenditures -15.56 million, giving a free cash flow of 1.14 billion.
| Operating Cash Flow | 1.15B |
| Capital Expenditures | -15.56M |
| Free Cash Flow | 1.14B |
| FCF Per Share | 1.54 |
Margins
| Gross Margin | n/a |
| Operating Margin | 63.85% |
| Pretax Margin | 61.54% |
| Profit Margin | 47.49% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 48.22% |
Dividends & Yields
This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 5.04%.
| Dividend Per Share | 0.75 |
| Dividend Yield | 5.04% |
| Dividend Growth (YoY) | 46.30% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 52.24% |
| Buyback Yield | -0.49% |
| Shareholder Yield | 4.56% |
| Earnings Yield | 10.21% |
| FCF Yield | 10.36% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |